Touchard, Cyril
Aubry, Alexandra
Eloy, Philippine
Bréchot, Nicolas
Lebreton, Guillaume
Franchineau, Guillaume
Besset, Sebastien
Hékimian, Guillaume
Nieszkowska, Ania
Leprince, Pascal
Luyt, Charles-Edouard
Combes, Alain
Schmidt, Matthieu
Article History
Received: 17 January 2018
Accepted: 9 July 2018
First Online: 19 August 2018
Ethics approval and consent to participate
: The study protocol was in accordance with the ethical standards of our hospital’s Institutional Review Board (Committee for the Protection of Human Subjects). In accordance with French law, informed consent was not obtained for demographic, physiological and hospital-outcome data analyses because this observational study did not modify existing diagnostic or therapeutic strategies. However, patients and/or relatives were informed about the anonymous data collection and that they could decline inclusion. This database was registered at the Commission Nationale l’Informatique et des Libertés (CNIL, registration number 1950673).
: In accordance with French law, informed consent was not obtained for demographic, physiological and hospital-outcome data analyses because this observational study did not modify existing diagnostic or therapeutic strategies. However, patients and/or relatives were informed about the anonymous data collection and that they could decline inclusion.
: Alain Combes has received lecture fees from Baxter and Gettinge and is the primary investigator of the EOLIA trial (NCT01470703), partly supported by Maquet-Gettinge. Matthieu Schmidt has received lectures fees from Gettinge and Dräger. The remaining authors have no conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.